Clinical Research Directory
Browse clinical research sites, groups, and studies.
The ENHANCE Study: taVNS and Psilocybin
Sponsor: University of Wisconsin, Madison
Summary
This study will examine whether combining a single dose of psilocybin with non-invasive transcutaneous auricular vagus nerve stimulation (taVNS), a potential inducer of neuroplasticity and enhanced memory formation, will enhance the long-term beneficial behavioral effects of psilocybin when compared to sham taVNS or no VNS by allowing memory for insights gained during the psychedelic experience to remain vivid after they will have faded in subjects who receive psilocybin followed by sham taVNS or no VNS.
Official title: Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2025-01-27
Completion Date
2028-01
Last Updated
2026-04-03
Healthy Volunteers
Yes
Interventions
Psilocybin
The psilocybin is produced under Good Manufacturing Practice and is in a capsule that contains 25 mg of botanically-derived psilocybin.
Transcutaneous auricular Vagus Nerve Stimulation (taVNS)
For both the active and sham taVNS procedure, participants will be provided with, and trained on, taVNS devices that apply gentle stimulation to the left ear via either electrodes or an earpiece that fits over the left ear.
Psychosocial Support Alone
Participants assigned to Psychosocial Support Alone will not receive taVNS following psilocybin dosing.
Sham taVNS
For both the active and sham taVNS procedure, participants will be provided with, and trained on, taVNS devices that apply gentle stimulation to the left ear via either electrodes or an earpiece that fits over the left ear.
Locations (1)
University of Wisconsin - Madison
Madison, Wisconsin, United States